By Izzy Wood (Drug Target Review)2023-01-20T09:42:18
US researchers outline the development of a new system for testing and developing CRISPR-based gene drives in the laboratory, and safely converting them into tools for potential real-world applications.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-06-15T08:00:00Z
2024-01-26T13:22:42
Sponsored by bit.bio
2023-07-04T10:05:58
Sponsored by Revvity
2025-05-08T10:38:52
Sponsored by Takara Bio USA
2024-05-10T11:23:31
Sponsored by BellBrook Labs
2025-05-14T14:30:00
Sponsored by Abzena
2026-05-25T07:00:00
Contributor Professor Neville Sanjana
Site powered by Webvision Cloud